A novel hypurgia for cancer chemotherapy: Programmable release of antineoplastics and cytothesis agents from core-shell micro-/nano-particles

Medical Hypotheses

Volumn 76, Issue 2, 2011, Pages 201-203

  Zhang, Yiqiong ^a   Wang, Bochu ^a   Wang, Yazhou ^a   Qiao, Weili ^a   Shao, Pengyu ^a  

^a CHONGQING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOTHESIS AGENT; NANOPARTICLE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CELL PROLIFERATION; CELL REGENERATION; CONCENTRATION RESPONSE; NANOENCAPSULATION; TUMOR CELL DESTRUCTION;

ANTINEOPLASTIC AGENTS; CELL MOVEMENT; ENDOTHELIUM, VASCULAR; HEPATOCYTE GROWTH FACTOR; HUMANS; MATERIALS TESTING; MICROSPHERES; MITOSIS; MODELS, THEORETICAL; NANOPARTICLES; NANOTECHNOLOGY; NEOPLASMS;

EID: 78651063422     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2010.09.029     Document Type: Article

References (24)

1. Sridhar T., Symonds R.P. Principles of chemotherapy and radiotherapy. Obstet Gyn Reprod Med 2009, 19:61-67.
2. Shin M., Larsson Lars-Inge, David M., Hougaard Kunio Fujiwara Daunomycin accumulation and induction of programmed cell death in rat hair follicles. Cell Tissue Res 2009, 337(3):429-438.
3. Senior J.R. Unintended hepatic adverse events associated with cancer chemotherapy. Toxicol Pathol 2010, 38(1):142-147.
4. Rubbia-Brandt L., Lauwers G.Y., Wang H.M., et al. Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis. Histopathology 2010, 56(4):430-439.
5. Haley B., Frenkel E. Nanoparticles for drug delivery in cancer treatment. Urol Oncol-Semin Ori 2008, 26(1):57-64.
6. Liu L., Jin P., Cheng M., Zhang G.L., Zhang F.B. 5-Fluorouracil-loaded self-assembled pH-sensitive nanoparticles as novel drug carrier for treatment of malignant tumors. Chin J Chem Eng 2006, 14(3):377-382.
7. Trumpp A., Essers M., Wilson A. Awakening dormant haematopoietic stem cells. Nat Rev Immunol 2010, 10(3):201-209.
8. Zhang W., Chu Y.Q., Ye Z.Y., Zhao Z.S., Tao H.Q. Expression of hepatocyte growth factor and basic fibroblast growth factor as prognostic indicators in gastric cancer. Anat Rec 2009, 292(8):1114-1121.
9. Rasola A., Fassetta M., De Bacco F., et al. A positive feedback loop between hepatocyte growth factor receptor and beta-catenin sustains colorectal cancer cell invasive growth. Oncogene 2007, 26(7):1078-1087.
10. Lin H., Civerolo E., Sahota, Groves R., Takahashi Y., Walker A. A high-throughput multi-locus pathogen detecting system for strain identification and population genetic studies of Xylella fastidiosa. Phytopathology 2005, 95(6):S61.
11. Jaklenec A., Hinckfuss A., Bilgen B., Ciombor D.M., Aaron R., Mathiowitz E., et al. Sequential release of bioactive IGF-I and TGF-beta(1) from PLGA microsphere-based scaffolds. Biomaterials 2008, 29(10):1518-1525.
12. Su Y., Li X.Q., Liu S.P., Mo X.M., Ramakrishna S. Controlled release of dual drugs from emulsion electrospun nanofibrous mats. Colloid Surf B-Biointerf 2009, 73(2):376-381.
13. Agnihotri S.A., Soppimath K.S., Betageri G.V. Controlled release application of multilamellar vesicles: a novel drug delivery approach. Drug Deliv 2010, 17(2):92-101.
14. Wang Y.Z., Wang B.C., Qiao W.L., Yin T.Y. A novel controlled release drug delivery system for multiple drugs based on electrospun nanofibers containing nanoparticles. J Pharm Sci-US 2010, 23:92-95. 10.1002/jps.22189.
15. Liu P., Wang B.C., Li J., Qiao W.L. Multi-anticancer drugs encapsulated in the micelle: a novel chemotherapy to cancer. Med Hypotheses 2008, 71:379-381.
16. Pana O., Teodorescu C.M., Chauvet O., et al. Structure, morphology and magnetic properties of Fe-Au core-shell nanoparticles. Surf Sci 2007, 601:4352-4357.
17. Chen A.Z., Li Y., Chen D., Hu J.Y. Development of core-shell microcapsules by a novel supercritical CO2 process. J Mater Sci-Mater M 2009, 20(3):751-758.
18. Lee S.H., Baek H.H., Kim J.H., Choi S.W. Core-shell poly(D, L-lactide-co-glycolide)/poly(ethyl2 -cyanoacrylate) microparticles with doxorubicin to reduce initial burst release. Macromol Res 2009, 17(12):1010-1014.
19. Ziyad S.Haidar, Reggie C.Hamdy, Maryam Tabrizian Protein release kinetics for core-shell hybrid nanoparticles based on the layer-by-layer assembly of alginate and chitosan on liposomes. Biomaterials 2008, 29:1207-1215.
20. Sandhiya S., Dkhar S.A., Surendiran A. Emerging trends of nanomedicine-an overview. Fund Clin Pharmacol 2009, 23(3):263-269.
21. Hwang Y.K., Jeong U., Cho E.C. Production of uniform-sized polymer core-shell microcapsules by coaxial electrospraying. Langmuir 2008, 24(6):2446-2451.
22. Koppolu B., Rahimi M., Nattama S., Wadajkar A., Nguyen K.T. Development of multiple-layer polymeric particles for targeted and controlled drug delivery. Nanomed NBM 2010, 6:355-361.
23. Ahmed F., Pakunlu R.I., Brannan A., Bates F., Minko T., Discher D.E. Biodegradable polymersomes loaded with both paclitaxel and doxorubicin permeate and shrink tumors, inducing apoptosis in proportion to accumulated drug. J Control Release 2006, 116(2):150-158.
24. Kim B.S., Oh J.M., Kim K., et al. BSA-FITC-loaded microcapsules for in vivo delivery. Biomaterials 2009, 30(5):902-909.